Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and is Destabilized by Inhibitors of Hsp90 Function
Overview
Affiliations
Hsp90 is a chaperone required for the conformational maturation of certain signaling proteins including Raf, cdk4, and steroid receptors. Natural products and synthetic small molecules that bind to the ATP-binding pocket in the amino-terminal domain of Hsp90 inhibit its function and cause the degradation of these client proteins. Inhibition of Hsp90 function in cells causes down-regulation of an Akt kinase-dependent pathway required for D-cyclin expression and retinoblastoma protein-dependent G(1) arrest. Intracellular Akt is associated with Hsp90 and Cdc37 in a complex in which Akt kinase is active and regulated by phosphatidylinositol 3-kinase. Functional Hsp90 is required for the stability of Akt in the complex. Occupancy of the ATP-binding pocket by inhibitors is associated with the ubiquitination of Akt and its targeting to the proteasome, where it is degraded. This results in a shortening of the half-life of Akt from 36 to 12 h and an 80% reduction in its expression. Akt and its activating kinase, PDK1, are the only members of the protein kinase A/protein kinase B/protein kinase C-like kinase family that are affected by Hsp90 inhibitors. Thus, transduction of growth factor signaling via the Akt and Raf pathways requires functional Hsp90 and can be coordinately blocked by its inhibition.
Advances in the structures, mechanisms and targeting of molecular chaperones.
Gu J, He Y, He C, Zhang Q, Huang Q, Bai S Signal Transduct Target Ther. 2025; 10(1):84.
PMID: 40069202 PMC: 11897415. DOI: 10.1038/s41392-025-02166-2.
Chen W, Chen X, Chen C, She S, Li X, Shan L Stem Cell Res Ther. 2025; 16(1):84.
PMID: 39988663 PMC: 11849194. DOI: 10.1186/s13287-025-04229-1.
Hajari N, Knoll M, Lu A, Barber-Axthelm I, Gale Jr M Virology. 2025; 603:110370.
PMID: 39765020 PMC: 11832110. DOI: 10.1016/j.virol.2024.110370.
AKT kinases as therapeutic targets.
Hassan D, Menges C, Testa J, Bellacosa A J Exp Clin Cancer Res. 2024; 43(1):313.
PMID: 39614261 PMC: 11606119. DOI: 10.1186/s13046-024-03207-4.
PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond.
Saber S, Abdelhady R, Elhemely M, Elmorsy E, Hamad R, Abdel-Reheim M Front Pharmacol. 2024; 15:1475998.
PMID: 39564119 PMC: 11573589. DOI: 10.3389/fphar.2024.1475998.